CompletedPhase 2NCT01062425
Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma
Studying Gliosarcoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Cancer Institute (NCI)
- Principal Investigator
- Tracy T Batchelor, MD MPHNRG Oncology
- Intervention
- 3-Dimensional Conformal Radiation Therapy(radiation)
- Enrollment
- 261 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2010 – 2022
Study locations (30)
- University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
- The Kirklin Clinic at Acton Road, Birmingham, Alabama, United States
- Arizona Oncology Services Foundation, Scottsdale, Arizona, United States
- Banner University Medical Center - Tucson, Tucson, Arizona, United States
- City of Hope Comprehensive Cancer Center, Duarte, California, United States
- Saint Joseph Hospital - Orange, Orange, California, United States
- Poudre Valley Hospital, Fort Collins, Colorado, United States
- Smilow Cancer Hospital Care Center at Saint Francis, Hartford, Connecticut, United States
- The Hospital of Central Connecticut, New Britain, Connecticut, United States
- Yale University, New Haven, Connecticut, United States
- Christiana Care Health System-Christiana Hospital, Newark, Delaware, United States
- AdventHealth Orlando, Orlando, Florida, United States
- Bay Medical Center, Panama City, Florida, United States
- Emory University Hospital Midtown, Atlanta, Georgia, United States
- Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
NRG Oncology · Radiation Therapy Oncology Group
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01062425 on ClinicalTrials.govOther trials for Gliosarcoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07134842A Study Assessing if it is Safe and Possible to Treat Brain Cancer Patients With Immunotherapy Before They Receive the Standard Treatment.University College, London
- ENROLLING BY INVITATIONPHASE1NCT06896110Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade GliomaAndrew P. Groves
- RECRUITINGPHASE1NCT06934889Study of ABBV-637 or ABBV-155 With ERAS-801 for People With GlioblastomaMemorial Sloan Kettering Cancer Center
- RECRUITINGNCT05756985Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain TissueBaptist Health South Florida
- RECRUITINGPHASE2NCT05864534Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed GlioblastomaNorthwestern University
- RECRUITINGNCT06954636Prognostic Potential of Olfactory Function in Glioblastoma: a Prospective Observational StudySied Kebir
- RECRUITINGPHASE1NCT04991870Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBMM.D. Anderson Cancer Center
- RECRUITINGPHASE1NCT05363826Intracavitary Photodynamic Therapy as an Adjuvant to Resection of Glioblastoma or Gliosarcoma Using IV Photobac®Photolitec LLC